In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Surname, first name, pseudonym, personal image ? can they be regisrtered as a trademark in the Polish Patent Office or EUIPO?

Author: Agnieszka Skrzypczak On 24 March 2016 a Spanish company, Gaudí BCN Projects S.L., filed Czytaj dalej

Patpol and Patpol Legal at the Intelligent Development Forum 2021

The Intelligent Development Forum, an interesting event, which our representatives could not miss, has just Czytaj dalej

What a trademark is like everyone can see… but, is it so obvious indeed? Part 4 – a color

The issue of what a trademark is and what is its legal definition was discussed Czytaj dalej